Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Anal Cancer
2		Additional conditions recognized in this trial
			Anus Neoplasms
3		More general conditions related to this trial
			Anus Diseases
			Colorectal Neoplasms
			Digestive System Diseases
			Digestive System Neoplasms
			Gastrointestinal Diseases
			Gastrointestinal Neoplasms
			Intestinal Diseases
			Intestinal Neoplasms
			Neoplasms
			Neoplasms by Site
			Rectal Diseases
			Rectal Neoplasms
4		Interventions listed in this trial
			cisplatin
			fluorouracil
			mitomycin C
			radiation therapy
5		Additional drug interventions recognized in this trial
			Mitomycin
			Mitomycins
6		More general drug interventions related to this trial
			Alkylating Agents
			Antibiotics, Antineoplastic
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antineoplastic Agents
			Enzyme Inhibitors
			Immunologic Factors
			Immunosuppressive Agents
			Molecular Mechanisms of Pharmacological Action
			Nucleic Acid Synthesis Inhibitors
			Pharmacologic Actions
			Physiological Effects of Drugs
			Radiation-Sensitizing Agents
			Therapeutic Uses
7		Sponsors listed in this trial
			Radiation Therapy Oncology Group
			National Cancer Institute (NCI)
			Eastern Cooperative Oncology Group
			Cancer and Leukemia Group B
			Southwest Oncology Group
			North Central Cancer Treatment Group